Toxicological Research

Korean Society of Toxicology & Korea Environmental Mutagen Society (한국독성학회)
권호 표지
DOI QR코드

DOI QR Code

Permitted Daily Exposure for Diisopropyl Ether as a Residual Solvent in Pharmaceuticals

  • Received : 2017.09.13
  • Accepted : 2018.02.05
  • Published : 2018.04.15
Download PDF
⟨ Previous Next ⟩

Abstract

Solvents can be used in the manufacture of medicinal products provided their residual levels in the final product comply with the acceptable limits based on safety data. At worldwide level, these limits are set by the "Guideline Q3C (R6) on impurities: guideline for residual solvents" issued by the ICH. Diisopropyl ether (DIPE) is a widely used solvent but the possibility of using it in the pharmaceutical manufacture is uncertain because the ICH Q3C guideline includes it in the group of solvents for which "no adequate toxicological data on which to base a Permitted Daily Exposure (PDE) was found". We performed a risk assessment of DIPE based on available toxicological data, after carefully assessing their reliability using the Klimisch score approach. We found sufficiently reliable studies investigating subchronic, developmental, neurological toxicity and carcinogenicity in rats and genotoxicity in vitro. Recent studies also investigated a wide array of toxic effects of gasoline/DIPE mixtures as compared to gasoline alone, thus allowing identifying the effects of DIPE itself. These data allowed a comprehensive toxicological evaluation of DIPE. The main target organs of DIPE toxicity were liver and kidney. DIPE was not teratogen and had no genotoxic effects, either in vitro or in vivo. However, it appeared to increase the number of malignant tumors in rats. Therefore, DIPE could be considered as a non-genotoxic animal carcinogen and a PDE of 0.98 mg/day was calculated based on the lowest No Observed Effect Level (NOEL) value of $356mg/m^3$ (corresponding to 49 mg/kg/day) for maternal toxicity in developmental rat toxicity study. In a worst-case scenario, using an exceedingly high daily dose of 10 g/day, allowed DIPE concentration in pharmaceutical substances would be 98 ppm, which is in the range of concentration limits for ICH Q3C guideline class 2 solvents. This result might be considered for regulatory decisions.

Keywords

References

  1. OECD, Environment Directorate (2009) The 2007 OECD List of High Production Volume Chemicals. Available from: http://www.oecd.org/officialdocuments/publicdisplaydocumentpdf/?cote=ENV/JM/MONO(2009)40&doclanguage=en/.
  2. Harrington, P.J. (2011) Pharmaceutical Process Chemistry for Synthesis: Rethinking the Routes to Scale-Up. John Wiley & Sons, Hoboken, NJ, USA.
  3. Sittig, M. (2013) Pharmaceutical Manufacturing Encyclopedia (3rd edition), William Andrew Publishing, Norwich, NY, USA.
  4. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH) (2016) Guideline for Residual Solvents Q3C (R6), 2016.
  5. Klimisch, H.J., Andreae, M. and Tillmann, U. (1997) A systematic approach for evaluating the quality of experimental toxicological and ecotoxicological data. Regul. Toxicol. Pharmacol., 25, 1-5. https://doi.org/10.1006/rtph.1996.1076
  6. Clark, C.R., Schreiner, C.A., Parker, C.M., Gray, T.M. and Hoffman, G.M. (2014) Health assessment of gasoline and fuel oxygenate vapors: subchronic inhalation toxicity. Regul. Toxicol. Pharmacol., 70, S18-S28. https://doi.org/10.1016/j.yrtph.2014.07.003
  7. O'Callaghan, J.P., Daughtrey, W.C., Clark, C.R,. Schreiner, C.A. and White, R. (2014) Health assessment of gasoline and fuel oxygenate vapors: neurotoxicity evaluation. Regul. Toxicol. Pharmacol., 70, S35-S42. https://doi.org/10.1016/j.yrtph.2014.05.002
  8. Roberts, L.G., Gray, T.M., Marr, M.C., Tyl, R.W., Trimmer, G.W., Hoffman, G.M., Murray, F.J., Clark, C.R. and Schreiner C.A. (2014) Health assessment of gasoline and fuel oxygenate vapors: developmental toxicity in rats. Regul. Toxicol. Pharmacol., 70, S69-S79. https://doi.org/10.1016/j.yrtph.2014.05.009
  9. Gray, T.M., Steup, D., Roberts, L.G., O'Callaghan, J.P., Hoffman, G., Schreiner, C.A. and Clark, C.R. (2014) Health assessment of gasoline and fuel oxygenate vapors: reproductive toxicity assessment. Regul. Toxicol. Pharmacol., 70, S48-S57. https://doi.org/10.1016/j.yrtph.2014.04.014
  10. White, K.L., Jr., Peachee, V.L., Armstrong, S.R., Twerdok, L.E., Clark, C.R. and Schreiner, C.A. (2014) Health assessment of gasoline and fuel oxygenate vapors: immunotoxicity evaluation. Regul. Toxicol. Pharmacol., 70, S43-S47. https://doi.org/10.1016/j.yrtph.2014.04.010
  11. Schreiner, C.A., Hoffman, G.M., Gudi, R. and Clark, C.R. (2014) Health assessment of gasoline and fuel oxygenate vapors: micronucleus and sister chromatid exchange evaluations. Regul. Toxicol. Pharmacol., 70, S29-S34. https://doi.org/10.1016/j.yrtph.2014.05.014
  12. Dalbey, W. and Feuston, M. (1996) Subchronic and developmental toxicity studies of vaporized diisopropyl ether in rats. J. Toxicol. Environ. Health, 49, 29-43. https://doi.org/10.1080/009841096160970
  13. United States Environmental Protection Agency (1998) Health Effects Test Guidelines OPPTS 870.3465 90-Day Inhalation Toxicity. EPA 712-C-98-204.
  14. Chernoff, N. and Rogers, J.M. (2004) Supernumerary ribs in developmental toxicity bioassays and in human populations: incidence and biological significance. J. Toxicol. Environ. Health B Crit. Rev., 7, 437-449. https://doi.org/10.1080/10937400490512447
  15. OECD (2001) Guideline for the Testing of Chemicals 414. Prenatal Developmental Toxicity Study.
  16. United States Environmental Protection Agency (1998) Health Effects Test Guidelines OPPTS 870.3700 Prenatal Developmental Toxicity Studies. EPA 712-C-98-207.
  17. Rodriguez, S.C. and Dalbey, W. (1997) Subchronic neurotoxicity of vaporized diisopropyl ether in rats. Int. J. Toxicol., 16, 599-610. https://doi.org/10.1080/109158197226919
  18. United States Environmental Protection Agency (1996) Health Effects Test Guidelines OPPTS 870.6200 Neurotoxicity Screening Battery. EPA-712-C-96-238.
  19. Brooks, T., Meyer, A. and Hutson, D. (1988) The genetic toxicology of some hydrocarbon and oxygenated solvents. Mutagenesis, 3, 227-232. https://doi.org/10.1093/mutage/3.3.227
  20. OECD (1997) Guideline for the Testing of Chemicals 471. Bacterial Reverse Mutation Test.
  21. OECD (1986) Guideline for the Testing of Chemicals 481. Genetic Toxicology: Saccharomyces cerevisiae Mitotic Recombinant Assay.
  22. OECD (1983) Guideline for the Testing of Chemicals 473. Genetic Toxicology: In Vitro Mammalian Cytogenetic Test.
  23. International Conference on Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (2011) Guideline S2 (R1) on Genotoxicity Testing and Data Interpretation for Pharmaceuticals Intended for Human Use.
  24. Belpoggi, F., Soffritti, M., Minardi, F., Bua, L., Cattin, E. and Maltoni, C. (2002) Results of long-term carcinogenicity bioassays on tert-amyl-methyl-ether (TAME) and di-isopropyl-ether (DIPE) in rats. Ann. N.Y. Acad. Sci., 982, 70-86.
  25. OECD (2009) Guideline for Testing of Chemicals 451. Carcinogenicity Studies.
  26. Cruzan, G., Borghoff, S.J., de Peyster, A., Hard, G.C., McClain, M., McGregor, D.B. and Thomas, M.G. (2007) Methyl tertiary-butyl ether mode of action for cancer endpoints in rodents. Regul. Toxicol. Pharmacol., 47, 156-165. https://doi.org/10.1016/j.yrtph.2006.09.003
  27. Phillips, S., Palmer, R.B. and Brody, A. (2008) Epidemiology, toxicokinetics, and health effects of methyl tert-butyl ether (MTBE). J. Med. Toxicol., 4, 115-126. https://doi.org/10.1007/BF03160966
  28. European Food Safety Authority (EFSA) (2009) Updated opinion on a request from the European Commission related to the 2nd ERF carcinogenicity study on aspartame, taking into consideration study data submitted by the Ramazzini Foundation in February 2009. EFSA J., 7, 1-18.
  29. Gift, J.S., Caldwell, J.C., Jinot, J., Evans, M.V., Cote, I. and Vanderberg, J.J. (2013) Scientific considerations for evaluating cancer bioassays conducted by the Ramazzini institute. Environ. Health Perspect., 121, 1253-1263.
  30. National Toxicology Program (NTP) (2011) Summary Report of the National Toxicology Program and Environmental Protection Agency Sponsored Review of Pathology Materials from Selected Ramazzini Institute Rodent Cancer Bioassays. Available from: https://ntp.niehs.nih.gov/ntp/about_ntp/partnerships/international/summarypwg_report_ri_bioassays.pdf/.
  31. Henley, M., Letinski, D.J., Carr, J., Caro, M.L., Daughtrey, W. and White, R. (2014) Health assessment of gasoline and fuel oxygenate vapors: generation and characterization of test materials. Regul. Toxicol. Pharmacol., 70, S13-S17. https://doi.org/10.1016/j.yrtph.2014.05.012
  32. United States Environmental Protection Agency (1994) Good Laboratory Practice Standards 79.60, CFR vol. 59, No. 122.
  33. OECD (2009) Guideline for Testing of Chemicals 413. Subchronic Inhalation Toxicity: 90-Day Study.
  34. Swenberg, J.A. (1993) Alpha 2u-globulin nephropathy: review of the cellular and molecular mechanisms involved and their implications for human risk assessment. Environ. Health Perspect., 101(Suppl 6), 39-44.
  35. United States Environmental Protection Agency (1991) Alpha2u-Globulin: Association with Chemically Induced Renal Toxicity and Neoplasia in the Male Rat. EPA/625/3-91/019F.
  36. O'Callaghan, J.P. and Sriram, K. (2005) GFAP and other glial proteins as biomarkers of neurotoxicity. Exp. Opin. Drug Saf., 4, 433-442. https://doi.org/10.1517/14740338.4.3.433
  37. OECD (1997) Guideline for the Testing of Chemicals 424. Neurotoxicity Study in Rodents.
  38. OECD (1983) Guideline for the Testing of Chemicals 415. One-Generation Reproduction Toxicity Study.
  39. United States Environmental Protection Agency (1998) Health Effects Test Guidelines OPPTS 870.3800 Reproduction and Fertility Effects. EPA 712-C-98-208.
  40. United States Environmental Protection Agency (1998) Health Effects Test Guidelines 870.7800, Immunotoxicity. EPA 712-C-98-351.
  41. United States Environmental Protection Agency (1998) Health Effects Test Guidelines 870.5395 Mammalian Erythrocyte Micronucleus Test. EPA 712-C-98-226.
  42. United States Environmental Protection Agency (1998) Health Effects Test Guidelines OPPTS 870.5915 In vivo sister chromatid exchange. EPA 712-C-98-235.
  43. Bernauer, U., Amberg, A., Scheutzow, D. and Dekant, W. (1998) Biotransformation of 12C- and 2-13C-labeled methyl tert-butyl ether, ethyl tert-butyl ether, and tert-butyl alcohol in rats: identification of metabolites in urine by 13C nuclear magnetic resonance and gas chromatography/mass spectrometry. Chem. Res. Toxicol., 11, 651-658. https://doi.org/10.1021/tx970215v
  44. Amberg, A., Rosner, E. and Dekant, W. (2000) Biotransformation and kinetics of excretion of ethyl tert-butyl ether in rats and humans. Toxicol. Sci., 53, 194-201. https://doi.org/10.1093/toxsci/53.2.194
  45. Shamsipur, M., MiranBeigi, A.A., Teymouri, M., Poursaberi, T., Mostafavi, S.M., Soleimani, P., Chitsazian, F. and Tash, S.A. (2012) Biotransformation of methyl tert-butyl ether by human cytochrome P450 2A6. Biodegradation, 23, 311-318. https://doi.org/10.1007/s10532-011-9510-0
  46. Casazza, J.P., Felver, M.E. and Veech, R.L. (1984) The metabolism of acetone in rat. J. Biol. Chem., 259, 231-236.
  47. Hazardous Substances Data Bank (2005) Isopropyl Ether. [cited 2017 Jul 4]. Available from: https://toxnet.nlm.nih.gov/cgi-bin/sis/search2/f?./temp/-4y1FdJ:1/.
  48. Fiserova-Bergerova, V. (1985) Toxicokinetics of organic solvents. Scand. J. Work. Environ. Health, 11, 7-21. https://doi.org/10.5271/sjweh.2261
  49. Lee, M.J. and Kim, H.Y. (2017) A 90-day inhalation toxicity study of ethyl formate in rats. Toxicol. Res., 33, 333-342. https://doi.org/10.5487/TR.2017.33.4.333
  50. Amberg, A., Rosner, E. and Dekant, W. (2001) Toxicokinetics of methyl tert-butyl ether and its metabolites in humans after oral exposure. Toxicol. Sci., 61, 62-67. https://doi.org/10.1093/toxsci/61.1.62